Feb 10 2025 9 mins 25
In this episode, we explore the efficacy and safety of iloperidone in treating bipolar disorder, examining new phase 3 trial data that reveals both promising results for mania symptoms and important considerations about side effects. Can this antipsychotic's favorable EPS profile outweigh its metabolic risks?
Faculty: Paul Zarkowski, M.D.
Host: Richard Seeber, M.D.
